A selection of major announcements

1. China Unicom Hong Kong: Net profit for the first three quarters was 17.25 billion yuan, up 10.1% from the same period last year

$CHINA UNICOM (00762.HK)$According to the announcement, revenue for the first three quarters was 281,693 billion yuan (RMB, same below), up 6.7% from the same period last year; profit attributable to equity holders of the company was 17.246 billion yuan, up 10.1% from the same period last year.

2. CNOOC: Net profit for the first three quarters was 97.645 billion yuan, a year-on-year decrease of 10.23%

$CNOOC (00883.HK)$According to the announcement, in the first three quarters of this year, CNOOC achieved revenue of 306.817 billion yuan, a year-on-year decrease of 1.39%; achieved unaudited oil and gas sales revenue of about 238.40 billion yuan, a year-on-year decrease of 10.3%. The main reason was that the increase in production partially offset the impact of the decline in international oil prices; and net profit of 97.645 billion yuan, a year-on-year decrease of 10.23%. In the first three quarters, the company's net output reached 500 million barrels of oil equivalent, up 8.3% year-on-year, a record high for the same period.

3. GAC Mitsubishi's restructuring plan settled: it will become a wholly-owned subsidiary of GAC Group

$GAC GROUP (02238.HK)$An announcement was issued. Following agreement among all shareholders, it is proposed to implement restructuring matters such as equity adjustments for GAC Mitsubishi and Guangsan Sales Company. The shareholders of the three parties will jointly increase their investment to settle debts. Of these, the Guangzhou Automobile Group will invest no more than 1,577 billion yuan, and will sell Mitsubishi Motors at a price of 1 yuan, respectively,$MITSUBISHI CORP (MSBHF.US)$It holds 30% and 20% of the shares in GAC Mitsubishi. After the transfer is completed, GAC Mitsubishi will become a wholly-owned subsidiary of the company. At the same time, it will use its existing core assets to expand the production capacity of its subsidiary GAC Aian to resolve production capacity bottlenecks.

At the same time, in order to guarantee the needs of daily operating capital, the shareholders of the three parties plan to increase the capital of the Guangsan Sales Company by 450 million yuan after completing the transfer, of which the company's capital will increase by 225 million yuan.

4. Cansino Biology and Gates Foundation sign funding agreement for restructured polio vaccine project

$CANSINOBIO (06185.HK)$According to the announcement, the company recently signed a project funding agreement with the Bill & Melinda Gates Foundation for a recombinant polio vaccine (“VLP-IPV”). Under the agreement, the Gates Foundation will provide the company with project funding totaling more than $2 million to support the company's development of VLP-IPV, a polio vaccine based on virus-likeparticles (VLPs). Based on the company's protein structure design and VLP assembly technology development, VLP-IPV is expected to contribute to global control and even eradication of polio.

Earnings Report

$CHINA UNICOM (00762.HK)$Hong Kong: Net profit for the first three quarters was $17.25 billion, up 10.1% from the same period last year

$CNOOC (00883.HK)$: Net profit for the first three quarters was 97.645 billion yuan, a year-on-year decrease of 10.23%

$LIVZON PHARMA (01513.HK)$: Net profit attributable to shareholders for the first three quarters was 1,602 billion yuan, an increase of 6.29% over the previous year

$FOSUN TOURISM (01992.HK)$: The tourism operation business revenue for the third quarter was 14.191 billion yuan, up about 19.4% year-on-year

$WH GROUP (00288.HK)$: Net profit of US$585 million was achieved in the first three quarters, a year-on-year decrease of 29.86%

$L'OCCITANE (00973.HK)$: Sales in the first half of the fiscal year reached 1,072 million euros, and the Americas continued to be the best performing region

$TIANLI INT HLDG (01773.HK)$Profit: Expected annual profit of about 330 million yuan, an increase of about 240% over the previous year

Operational data

$CHINA RAIL CONS (01186.HK)$The cumulative amount of new contracts signed in the first three quarters was 1.79 trillion yuan, a year-on-year decrease of 3.12%

$CGN MINING (01164.HK)$: A total of 672.0tU of natural uranium was produced in the third quarter, with a planned completion rate of 99.6%.

Pharmaceutical Innovation

$CANSINOBIO (06185.HK)$: Signed a funding agreement with the Bill & Melinda Gates Foundation for a recombinant polio vaccine project

$SH PHARMA (02607.HK)$: Approved production of lacosamide injections and oral solutions

$GRANDPHARMA (00512.HK)$: The Group's global innovative ophthalmology drug GPN00833 completed phase III clinical trial of the first patient enrolled in the group

$FOSUN PHARMA (02196.HK)$The holding subsidiary Xingsheng Xinhui received approval for clinical trials of XS-03 tablets

Acquisition and sale

$CHINA OVERSEAS (00688.HK)$Set up a joint venture to obtain land use rights in Shanghai at a cost of 24 billion yuan

Repurchase cancellation

$AIA (01299.HK)$On October 24, 2,042,000 shares were repurchased at a cost of HK$135 million

$DONGFENG GROUP (00489.HK)$On October 24, 13.266,000 shares were repurchased at a cost of HK$42.994 million

$ESR (01821.HK)$On October 24, 1.52 million shares were repurchased at a cost of HK$15.744,800

$FOSUN INTL (00656.HK)$On October 24, 1.16 million shares were repurchased at a cost of HK$5.35 million

$HSBC HOLDINGS (00005.HK)$On October 23, 1,072,500 shares were bought back at a cost of £6571,500

$STANCHART (02888.HK)$On October 23, 2.102 million shares were bought back at a cost of £15.105 million

$BEKE-W (02423.HK)$On October 23, 650,000 shares were bought back at a cost of $3.23 million

Editor/Corrine